# Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions

> **NCT03041766** · PHASE2 · COMPLETED · sponsor: **Oswaldo Cruz Foundation** · enrollment: 30 (actual)

## Conditions studied

- Schistosomiasis

## Interventions

- **BIOLOGICAL:** Sm14
- **DRUG:** GLA-SE solution

## Key facts

- **NCT ID:** NCT03041766
- **Lead sponsor:** Oswaldo Cruz Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-06
- **Primary completion:** 2017-04-06
- **Final completion:** 2017-06-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-12-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03041766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03041766, "Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03041766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*